Exacerbation causes among inflammatory bowel disease patients in Guilan Province north of Iran

Abstract

Objective Numerous factors may contribute as triggers to the exacerbation of the condition of patients with inflammatory bowel disease. Methods The medical files of 109 patients with the positive history of inflammatory bowel disease exacerbation between March 2016 and March 2017 were assessed retrospectively. Data were obtained using the inflammatory bowel disease data bank software. The parameters were obtained from the inflammatory bowel disease data bank software. The mentioned parameters were assessed in terms of type and severity of disease using chi-square test in SPSS software. Moreover, binary logistic regression test was used to assess the associations between season of disease onset and inflammatory bowel disease exacerbation as odds ratios with 95% confidence intervals (95% CI). Results Overall, (88.1%) of cases with inflammatory bowel disease exacerbation, had ulcerative colitis. The mean age of patients was 38.14 ± 14.66 years. The disease duration in all patients (ulcerative colitis and Crohn's disease) was 35.43 and 38.85 months, respectively. About 50% of patients with infection were strongyloides stercoralis positive. The occurrence of mild inflammatory bowel disease exacerbation was significantly higher in spring in comparison to other seasons (OR = 3.58; 95% CI 0.1–1.04). Most patients with ulcerative colitis were prescribed salicylates alone (53.12%). Most patients with Crohn's disease with mild and severe activity were non-smokers ( p = 0.058). This difference was marginally significant. Conclusion It is suggested that in future studies, the evidences of distribution of SS infections among patients with inflammatory bowel disease and the history of exacerbation along with other environmental factors such as enhancing nutritional quality and surface water be taken into consideration.

Current insight into enteropathogens in flare-up ulcerative colitis. An observational study

“…Among ulcerative colitis patients, enteric infections were found in 85.3% which was within the range of the earlier estimates (9–89%) [4,17,18]. Similarly, it was revealed that enteric infections were more common in ulcerative colitis patients as stated in the literature [19,20].…”

Effects of coenzyme Q10 on health-related quality of life, clinical disease activity and blood pressure in patients with mild to moderate ulcerative colitis: a randomized clinical trial

“…Population-based studies indicated that the incidence and prevalence of IBD are rising rapidly in low- and middle-income countries that have become a global disease in the 21st century ( 4 , 5 ). A recent nationwide report in Iran showed that the national incidence and prevalence of IBD and its burden appears to have similar trends ( 6 , 7 ). The majority of patients suffer from intestinal complications of UC, such as cramping, diarrhea, hematochezia, and urgency to defecate, as well as experience adverse treatment effects ( 3 , 8 ).…”